Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

769
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
769
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

168
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
168
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

23
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

678
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
678
Angina IV: Management01:26

Angina IV: Management

10
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
10

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chinese expert consensus on the choice of initial cholesterol-lowering strategy.

Frontiers in pharmacology·2026
Same author

Chinese Expert Consensus on the Clinical Diagnosis and Management of Statin Intolerance.

Clinical pharmacology and therapeutics·2024
Same author

2023 Chinese guideline for lipid management.

Frontiers in pharmacology·2023
Same author

New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients.

Lipids in health and disease·2018
Same author

New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases.

Lipids in health and disease·2018
Same author

The eyes are the window to the heart: one case of cardiac amyloidosis with eyelid swelling as the initial symptom.

Journal of geriatric cardiology : JGC·2018
Same journal

Association of apolipoprotein C-III with atherosclerotic cardiovascular disease and the effectiveness of simulated interventions.

Journal of geriatric cardiology : JGC·2026
Same journal

Very late giant device-related thrombosis on the patent foramen ovale occluder after combined closure of left atrial appendage and patent foramen ovale: a case report and literature review.

Journal of geriatric cardiology : JGC·2026
Same journal

Comparison between automated electronic blood pressure monitor and electrocardiography in atrial fibrillation screen.

Journal of geriatric cardiology : JGC·2026
Same journal

An unexpected finding during right heart catheterization: isolated persistent left superior vena cava.

Journal of geriatric cardiology : JGC·2026
Same journal

Examining short-term and long-term outcomes in octogenarians undergoing isolated surgical aortic valve replacement.

Journal of geriatric cardiology : JGC·2026
Same journal

Rationale and design of the Early Initiation of Intensification Lipid-Lowering Treatment in Acute Coronary Syndrome (ELITE-ACS): a real-world study.

Journal of geriatric cardiology : JGC·2026
See all related articles

Related Experiment Video

Updated: Jul 13, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.7K

2023 China Guidelines for Lipid Management.

Jian-Jun Li1, Shui-Ping Zhao2, Dong Zhao3

  • 1National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China.

Journal of Geriatric Cardiology : JGC
|October 16, 2023
PubMed
Summary
This summary is machine-generated.

New China guidelines emphasize low-density lipoprotein cholesterol (LDL-C) management for atherosclerotic cardiovascular disease (ASCVD) prevention. They recommend statins as initial treatment, with other therapies for high-risk individuals, guiding clinical practice across all age groups.

More Related Videos

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.0K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.0K

Related Experiment Videos

Last Updated: Jul 13, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.7K
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.0K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.0K

Area of Science:

  • Cardiology
  • Public Health
  • Endocrinology

Background:

  • Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of mortality in China.
  • Elevated low-density lipoprotein cholesterol (LDL-C) is a significant risk factor for ASCVD.
  • The increasing burden of ASCVD necessitates updated lipid management strategies.

Purpose of the Study:

  • To revise and adapt existing dyslipidemia guidelines into the new "China Guidelines for Lipid Management".
  • To provide updated recommendations for lipid control based on global research breakthroughs.
  • To establish risk-stratified target LDL-C levels for diverse populations.

Main Methods:

  • An Experts' committee adapted the "Guidelines for the prevention and treatment of dyslipidemia".
  • The new guidelines utilize cardiovascular disease (CVD) risk stratification to determine target LDL-C values.
  • Recommendations include lifestyle modifications, moderate-intensity statin therapy, and additional agents like PCSK9 inhibitors.

Main Results:

  • LDL-C remains the primary target for lipid control.
  • Initial treatment involves moderate-intensity statins and lifestyle changes.
  • Cholesterol absorption inhibitors and PCSK9 inhibitors are recommended as second-line therapies.
  • Guidance is provided for lipid management across all age groups, from children to the elderly.

Conclusions:

  • The new guidelines aim to comprehensively improve lipid management in China.
  • They provide a framework for clinical practice to enhance ASCVD prevention and treatment.
  • Risk stratification is crucial for tailoring LDL-C targets and therapeutic strategies.